Liquid biopsy test commercially launched for detection of prostate cancer

January 3, 2020 Leave a comment

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the commercial launch of its Cchek™ Prostate Cancer Confirmation test (Cchek™ PCC)...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Anixa Biosciences

Liquid biopsy test commercially launched for detection of prostate cancer

Chloride ion channel ASOR is required for vesicle shrinkage

Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles

Damage-free and time-saving platform for continuous sorting and detection of exosomes and host cells in human serum

Predicine Liquid Biopsy Outperforms Four Other Leading ctDNA NGS Tests in a Study by Bristol Myers Squibb

Exosomes and their roles in the chemoresistance of pancreatic cancer

VivaZome to collaborate with the University of Queensland traumatic brain injury experts to develop exosome-based therapies